Annual Operating Profit
-$23.12 M
+$2.11 M+8.37%
31 December 2023
Summary:
Minerva Neurosciences annual operaing income is currently -$23.12 million, with the most recent change of +$2.11 million (+8.37%) on 31 December 2023. During the last 3 years, it has fallen by -$24.97 million (-1351.94%). NERV annual operating profit is now -1351.94% below its all-time high of $1.85 million, reached on 31 December 2020.NERV Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$4.37 M
+$1.91 M+30.44%
30 September 2024
Summary:
Minerva Neurosciences quarterly operating income is currently -$4.37 million, with the most recent change of +$1.91 million (+30.44%) on 30 September 2024. Over the past year, it has increased by +$1.71 million (+28.17%). NERV quarterly operating profit is now -114.80% below its all-time high of $29.51 million, reached on 30 June 2020.NERV Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$24.50 M
+$1.71 M+6.53%
30 September 2024
Summary:
Minerva Neurosciences TTM operating income is currently -$24.50 million, with the most recent change of +$1.71 million (+6.53%) on 30 September 2024. Over the past year, it has dropped by -$3.48 million (-16.56%). NERV TTM operating profit is now -470.58% below its all-time high of $6.61 million, reached on 31 March 2021.NERV TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.4% | +28.2% | -16.6% |
| 3 y3 years | -1351.9% | +41.9% | +21.7% |
| 5 y5 years | +55.3% | +69.4% | +57.1% |
NERV Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1351.9% | +49.0% | at high | +79.6% | -21.6% | +46.6% |
| 5 y | 5 years | -1351.9% | +69.5% | -114.8% | +86.5% | -470.6% | +67.7% |
| alltime | all time | -1351.9% | +69.5% | -114.8% | +86.5% | -470.6% | +67.7% |
Minerva Neurosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.37 M(-30.4%) | -$24.50 M(-6.5%) |
| June 2024 | - | -$6.28 M(-6.1%) | -$26.21 M(+7.2%) |
| Mar 2024 | - | -$6.68 M(-6.8%) | -$24.45 M(+5.8%) |
| Dec 2023 | -$23.12 M(-8.4%) | -$7.17 M(+18.0%) | -$23.12 M(+10.0%) |
| Sept 2023 | - | -$6.08 M(+34.5%) | -$21.02 M(+4.3%) |
| June 2023 | - | -$4.52 M(-15.5%) | -$20.15 M(-10.8%) |
| Mar 2023 | - | -$5.35 M(+5.5%) | -$22.59 M(-10.5%) |
| Dec 2022 | -$25.23 M(-44.4%) | -$5.07 M(-2.6%) | -$25.23 M(-39.3%) |
| Sept 2022 | - | -$5.21 M(-25.2%) | -$41.54 M(-5.3%) |
| June 2022 | - | -$6.97 M(-12.8%) | -$43.85 M(-4.4%) |
| Mar 2022 | - | -$7.99 M(-62.6%) | -$45.85 M(+1.1%) |
| Dec 2021 | -$45.37 M(-2556.6%) | -$21.38 M(+184.4%) | -$45.37 M(+45.0%) |
| Sept 2021 | - | -$7.52 M(-16.1%) | -$31.29 M(-1.8%) |
| June 2021 | - | -$8.96 M(+19.4%) | -$31.86 M(-581.9%) |
| Mar 2021 | - | -$7.51 M(+2.8%) | $6.61 M(+258.0%) |
| Dec 2020 | $1.85 M(-102.4%) | -$7.30 M(-9.8%) | $1.85 M(-108.0%) |
| Sept 2020 | - | -$8.09 M(-127.4%) | -$23.22 M(-21.1%) |
| June 2020 | - | $29.51 M(-340.5%) | -$29.41 M(-59.0%) |
| Mar 2020 | - | -$12.27 M(-62.1%) | -$71.82 M(-5.3%) |
| Dec 2019 | -$75.87 M(+46.7%) | -$32.37 M(+126.6%) | -$75.87 M(+32.8%) |
| Sept 2019 | - | -$14.28 M(+10.7%) | -$57.13 M(+3.4%) |
| June 2019 | - | -$12.90 M(-20.9%) | -$55.27 M(-0.1%) |
| Mar 2019 | - | -$16.31 M(+19.7%) | -$55.30 M(+6.9%) |
| Dec 2018 | -$51.73 M | -$13.63 M(+9.7%) | -$51.73 M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$12.42 M(-3.9%) | -$47.63 M(+2.2%) |
| June 2018 | - | -$12.93 M(+1.5%) | -$46.62 M(+7.3%) |
| Mar 2018 | - | -$12.74 M(+33.7%) | -$43.43 M(+5.5%) |
| Dec 2017 | -$41.17 M(+36.4%) | -$9.53 M(-16.4%) | -$41.17 M(+0.7%) |
| Sept 2017 | - | -$11.41 M(+17.0%) | -$40.88 M(+8.4%) |
| June 2017 | - | -$9.75 M(-7.1%) | -$37.70 M(+14.5%) |
| Mar 2017 | - | -$10.49 M(+13.5%) | -$32.92 M(+9.0%) |
| Dec 2016 | -$30.19 M(+15.6%) | -$9.24 M(+12.2%) | -$30.19 M(+3.6%) |
| Sept 2016 | - | -$8.23 M(+65.8%) | -$29.15 M(+9.5%) |
| June 2016 | - | -$4.96 M(-36.0%) | -$26.62 M(-4.9%) |
| Mar 2016 | - | -$7.76 M(-5.3%) | -$27.99 M(+7.2%) |
| Dec 2015 | -$26.11 M(-52.4%) | -$8.19 M(+43.6%) | -$26.11 M(+3.0%) |
| Sept 2015 | - | -$5.70 M(-9.9%) | -$25.36 M(-45.8%) |
| June 2015 | - | -$6.33 M(+7.7%) | -$46.81 M(-19.5%) |
| Mar 2015 | - | -$5.88 M(-21.1%) | -$58.13 M(+5.9%) |
| Dec 2014 | -$54.87 M(+1628.2%) | -$7.45 M(-72.6%) | -$54.87 M(+10.9%) |
| Sept 2014 | - | -$27.15 M(+53.8%) | -$49.47 M(+117.0%) |
| June 2014 | - | -$17.65 M(+572.8%) | -$22.80 M(+312.5%) |
| Mar 2014 | - | -$2.62 M(+28.4%) | -$5.53 M(+74.1%) |
| Dec 2013 | -$3.17 M(+100.8%) | -$2.04 M(+323.3%) | -$3.17 M(+180.3%) |
| Sept 2013 | - | -$482.50 K(+27.4%) | -$1.13 M(+74.2%) |
| June 2013 | - | -$378.80 K(+39.6%) | -$650.10 K(+139.6%) |
| Mar 2013 | - | -$271.30 K | -$271.30 K |
| Dec 2012 | -$1.58 M | - | - |
FAQ
- What is Minerva Neurosciences annual operaing income?
- What is the all time high annual operating profit for Minerva Neurosciences?
- What is Minerva Neurosciences annual operating profit year-on-year change?
- What is Minerva Neurosciences quarterly operating income?
- What is the all time high quarterly operating profit for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly operating profit year-on-year change?
- What is Minerva Neurosciences TTM operating income?
- What is the all time high TTM operating profit for Minerva Neurosciences?
- What is Minerva Neurosciences TTM operating profit year-on-year change?
What is Minerva Neurosciences annual operaing income?
The current annual operating profit of NERV is -$23.12 M
What is the all time high annual operating profit for Minerva Neurosciences?
Minerva Neurosciences all-time high annual operaing income is $1.85 M
What is Minerva Neurosciences annual operating profit year-on-year change?
Over the past year, NERV annual operaing income has changed by +$2.11 M (+8.37%)
What is Minerva Neurosciences quarterly operating income?
The current quarterly operating profit of NERV is -$4.37 M
What is the all time high quarterly operating profit for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly operating income is $29.51 M
What is Minerva Neurosciences quarterly operating profit year-on-year change?
Over the past year, NERV quarterly operating income has changed by +$1.71 M (+28.17%)
What is Minerva Neurosciences TTM operating income?
The current TTM operating profit of NERV is -$24.50 M
What is the all time high TTM operating profit for Minerva Neurosciences?
Minerva Neurosciences all-time high TTM operating income is $6.61 M
What is Minerva Neurosciences TTM operating profit year-on-year change?
Over the past year, NERV TTM operating income has changed by -$3.48 M (-16.56%)